Ritalin and Cabergoline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ritalin (methylphenidate hydrochloride) and Cabergoline (cabergoline). Common drug interactions include biliary colic among females and hallucination, auditory among males.

The phase IV clinical study analyzes what interactions people have when they take Ritalin and Cabergoline. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.

What is Cabergoline?

Cabergoline has active ingredients of cabergoline. It is often used in prolactinoma. eHealthMe is studying from 6,257 Cabergoline users. Check the latest studies of Cabergoline.



On Jul, 16, 2026

14 people who take Ritalin and Cabergoline together, and have interactions are studied.

Ritalin and Cabergoline drug interactions.

What are the common drug interactions of Ritalin and Cabergoline, by gender? *:

female:

  1. Biliary colic
  2. Blood pressure increased
  3. Body temperature decreased
  4. Bone pain
  5. Decreased appetite
  6. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  7. Disturbance in attention
  8. Dizziness
  9. Dyspepsia (indigestion)
  10. Eating disorder

male:

  1. Hallucination, auditory (perceiving sounds without auditory stimulus)
  2. Hallucination, visual (seeing things that aren't there)
  3. Persecutory delusion
  4. Psychotic disorder

What are the common drug interactions of Ritalin and Cabergoline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Back disorder
  2. Back pain
  3. Biliary colic
  4. Blood pressure increased
  5. Body temperature decreased
  6. Bone pain
  7. Decreased appetite
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Disturbance in attention
  10. Dizziness

40-49:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Upper respiratory tract infection

50-59:

n/a

60+:

  1. Hallucination, auditory (perceiving sounds without auditory stimulus)
  2. Hallucination, visual (seeing things that aren't there)
  3. Persecutory delusion
  4. Psychotic disorder

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 42.86%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 28.57%
  3. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 4 people, 28.57%
  4. Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 3 people, 21.43%
  5. Drowsiness: 3 people, 21.43%
  6. Parkinson's Disease: 1 person, 7.14%
  7. High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and Cabergoline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ritalin and Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cabergoline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ritalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cabergoline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride and cabergoline (the active ingredients of Ritalin and Cabergoline, respectively), and Ritalin and Cabergoline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: